Related Experiment Video
Updated: Aug 7, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Screening for positive allosteric modulators of biological targets
1Abbott Laboratories, R4PN/J35, 200 Abbott Park Road, Abbott Park, IL 60064, USA. duke.groebe@abbott.com
Positive allosteric modulators offer targeted protein modulation for disease therapy. Current screening methods often miss these valuable therapeutic agents, necessitating improved discovery approaches.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Discovery
Background:
- Positive allosteric modulators (PAMs) are increasingly recognized for their therapeutic potential in human diseases.
- PAMs offer advantages like specificity, selectivity, and activity limits, reducing in vivo off-target effects.
- Existing high-throughput screening (HTS) paradigms are not optimized for PAM discovery, leading to potential oversight of hits.
Purpose of the Study:
- To highlight the benefits and challenges of discovering positive allosteric modulators.
- To propose considerations for improving the identification of PAMs in screening campaigns.
- To discuss the role of ligand concentration and kinetic analysis in PAM screening.
Main Methods:
- Analysis of current screening paradigms for their suitability in identifying PAMs.
- Consideration of ligand concentration effects within screening assays.
- Application of kinetic schemes to understand modulator-protein interactions.
Main Results:
- Current screening methods may overlook serendipitously discovered PAMs.
- Simple adjustments to screening conditions, particularly ligand concentration, can facilitate PAM discovery.
- Kinetic modeling provides a framework for understanding PAM behavior and optimizing screening.
Conclusions:
- Improved screening strategies are needed to effectively identify positive allosteric modulators.
- Understanding ligand concentration and kinetics is crucial for successful PAM discovery.
- Optimized screening will enhance the therapeutic application of PAMs in human diseases.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Related Concept Videos
Allosteric Regulation
Allosteric Regulation
Pharmacogenomics: Identification of New Drug Targets
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cooperative Allosteric Transitions